New stroke drug BB-031 enters human testing
Disease control
Recruiting now
This study tests a new drug called BB-031 in people who have had a stroke within the last 24 hours. About 228 participants will receive either the drug or a placebo, and researchers will check for safety, side effects, and how the drug works in the body over 90 days. The main goa…
Phase: PHASE2 • Sponsor: Basking Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC